Monitor for future Form 4 or Form 5 filings to determine whether Jain acquires or disposes of shares, which could signal confidence or concern. The lack of disclosed holdings limits immediate trading relevance.
Price Chart
Executive Summary
Rita Jain filed a Form 3 disclosing her initial beneficial ownership of securities in First Tracks Biotherapeutics, Inc. (TRAX), a biopharma company formerly known as Biopharma Company, Inc. The filing indicates she has taken on a reporting role, likely as an officer, director, or significant insider, but does not disclose specific share amounts or financial details.
Key Facts
- Rita Jain filed Form 3 for First Tracks Biotherapeutics, Inc. (TRAX) on April 1, 2026, reporting initial beneficial ownership.
- No specific number of shares or dollar value of holdings was disclosed in the available documents.
- The company is incorporated in Delaware, headquartered in San Diego, CA, and operates in the pharmaceutical preparations sector (SIC 2834).
- The company changed its name from Biopharma Company, Inc. to First Tracks Biotherapeutics, Inc. on October 10, 2025.
Financial Impact
undisclosed amount
Risk Factors
- Insufficient data to assess potential insider influence or ownership concentration.
- No indication of shareholding size, making it impossible to evaluate economic significance.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001707797-26-000004 |
| Document: 0001707797-26-000004-index.html | 0001707797-26-000004 |
| Document: 0001707797-26-000004.txt | 0001707797-26-000004 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $43.80 | awaiting T+1 | — | $44.05 (+0.57%) |
Oct 20, 2026 5d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $44.05 (+2.99%) |
Oct 15, 2026 10d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $44.05 (−27.83%) |
Oct 15, 2026 11d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $44.05 (−22.23%) |
Oct 13, 2026 13d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $44.05 (+39.05%) |
Aug 12, 2026 10w ago | 8-K | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 12, 2026 10w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 7, 2026 11w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $44.05 (−8.08%) |
Jun 22, 2026 17w ago | 8-K | $17.78 $16.69 | ▼ −6.13% | ▼ −6.08% | $44.05 (+147.75%) |
May 14, 2026 23w ago | 8-K | $16.90 $17.79 | ▲ +5.27% | ▲ +5.33% | $44.05 (+160.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers